Dear Colleagues, The AIDS Institute Bureau of Hepatitis Health Care and Epidemiology is pleased to announce the third Annual New York State (NYS) Hepatitis C Elimination Progress Report Meeting will be held virtually from 10 am – 2 pm on May 14, 2025, in collaboration with the New York City Department of Health and Mental Hygiene. The theme of this year’s […]
We are excited to announce the forthcoming launch of the “STI Dashboard NY: New York State’s Sexual Health Dashboard” (https://stidashboardny.org)! Launching early in 2025, the purpose of the Dashboard is to promote and improve sexual health in New York State by providing a web-based, publicly accessible tool to explore sexually transmitted infection (STI) data. The Dashboard […]
In June of 2024, the United States (US) Food and Drug Administration (FDA) approved Cepheid’s GeneXpert (XpertⓇHCV) for Point of Care (POC) hepatitis C (HCV) diagnostic testing, the first of its kind for HCV in the US. The test is CLIA (Clinical Laboratory Improvement Amendment) waived, meaning the instrument is simple to use and with […]
This blog post contains edited excerpts from a press release originally published by the CUNY Graduate School of Public Health & Health Policy. A pioneering study sheds new light on the hepatitis C (HCV) virus epidemic among young people who inject drugs in New York City. This research, led by Drs. Honoria Guarino and Pedro […]
In 2022, the hepatitis C (HCV) infection rate among 18–40 year-olds in New York State (NYS) was 4.0 per 100,000 population, a 27% decrease from 5.5 new HCV infections per 100,000 in 2020. These data are now available as interactive visualizations along with HCV diagnoses and treatment/clearance data on the HCV Dashboard. Users can explore […]
On May 15, 2024, New York State hosted the second Annual Hepatitis C Elimination Progress Report virtual meeting to share progress toward reaching its elimination goals, as outlined in the 2021 release of the New York State Hepatitis C Elimination Plan. All of the materials and presentations from the May meeting are now available: Hepatitis […]
In 2022 there were 5,169 people newly diagnosed with hepatitis C (HCV) in New York State (NYS), a 9% decrease from 2021, continuing the downward trend of HCV diagnoses over the previous decade. Between 2010 and 2022, 194,375 New Yorkers were diagnosed with HCV, and of those, 53% are known to have cleared their infection […]